IGMS — IGM Biosciences Share News
0.000.00%
Last trade - 00:00- $76.57m
- -$27.73m
- $2.68m
Brief: Igm Closes Upsized Public Offering & Concurrent Private Placement
U.S. STOCKS ON THE MOVE-Mosaic, Eli Lilly, I-Mab
U.S. STOCKS ON THE MOVE-Cidara Therapeutics, Crown Crafts, iRobot
IGM Biosciences surges after upsized equity raise
Brief: IGM Announces Pricing Of $107.3 Mln Upsized Public Offering And Concurrent Private Placement
Brief: IGM Announces Proposed Public Offering And Concurrent Private Placement
U.S. STOCKS ON THE MOVE-Centerra Gold, gold miners, Travere Therapeutics
U.S. STOCKS ON THE MOVE-VerifyMe, Intel, Hewlett Packard Enterprise
IGM Biosciences rises on FDA nod to lupus, RA treatment trials
Brief: IGM Biosciences Announces FDA Clearance To Begin Clinical Studies Of Lupus And Rheumatoid Arthritis Treatment
IGM Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: IGM Biosciences Announces First Quarter 2023 Financial Results
IGM Biosciences Inc expected to post a loss of $1.37 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Apple, Intel, Tesla
U.S. RESEARCH ROUNDUP- Cintas, Stryker, Zimmer Biomet Holdings
IGM Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: IGM Biosciences Inc Reports Quarterly Loss Per Share Of $1.19
IGM Biosciences Inc expected to post a loss of $1.25 a share - Earnings Preview
IGM Biosciences Inc expected to post a loss of $1.25 a share - Earnings Preview